Researchers evaluated the use of TNFis vs methotrexate in reducing the risk for progression to psoriatic arthritis in patients with psoriasis.
Observations and theories about the emergence of “COVID toes” in patients are discussed with Adam Friedman, MD, FAAD.
New registries have been established to capture emerging data on patients with psoriasis and atopic dermatitis who have COVID-19.
A study from Italy reports severe outcomes related to the COVID-19 infection in patients with chronic plaque psoriasis receiving immunosuppressive therapies.
The outbreak of COVID-19 affects the management of chronic dermatologic disease in those patients already receiving therapy and patients about to begin a new treatment.
An understanding of pathophysiology may serve to guide clinical decision making when using biologic agents during the COVID-19 pandemic.
The American Academy of Dermatology has established fluid protocols to protect clinicians and patients during the COVID-19 pandemic.
A panel of dermatologists outline how to implement a telehealth structure that allows for sustainable and scalable practice beyond the current crisis.
For insights on the effect of more vigilant personal hand hygiene and guidance on how best to maintain these practices while addressing concerns about skin disorders, we spoke with Joel Schlessinger, MD, a board-certified dermatologic surgeon.